Taiwan's biotech industry more advanced than Korea, Singapore

Around eight types of new drugs developed in Taiwan will be approved by the U.S. Food and Drug Administration in two or three years, surpassing South Korea and Singapore, Legislative Speaker Wang Jin-pyng said Friday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)